52 related articles for article (PubMed ID: 36899075)
1. Treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF
Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675
[TBL] [Abstract][Full Text] [Related]
3. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.
Hahn T; Wall D; Camitta B; Davies S; Dillon H; Gaynon P; Larson RA; Parsons S; Seidenfeld J; Weisdorf D; McCarthy PL
Biol Blood Marrow Transplant; 2005 Nov; 11(11):823-61. PubMed ID: 16275588
[TBL] [Abstract][Full Text] [Related]
4. Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers.
Hofmann G; Zierk J; Sobik B; Wotschofsky Z; Sembill S; Krumbholz M; Metzler M; Karow A
Sci Rep; 2023 Mar; 13(1):4022. PubMed ID: 36899075
[TBL] [Abstract][Full Text] [Related]
5. Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
Varda-Bloom N; Danylesko I; Shouval R; Eldror S; Lev A; Davidson J; Rosenthal E; Volchek Y; Shem-Tov N; Yerushalmi R; Shimoni A; Somech R; Nagler A
Oncotarget; 2017 Jan; 8(1):418-429. PubMed ID: 27880933
[TBL] [Abstract][Full Text] [Related]
6. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
Front Immunol; 2018; 9():1841. PubMed ID: 30154788
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
[TBL] [Abstract][Full Text] [Related]
8. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation.
Savani BN; Mielke S; Rezvani K; Montero A; Yong AS; Wish L; Superata J; Kurlander R; Singh A; Childs R; Barrett AJ
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1216-23. PubMed ID: 17889359
[TBL] [Abstract][Full Text] [Related]
9. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
Koehl U; Bochennek K; Zimmermann SY; Lehrnbecher T; Sörensen J; Esser R; Andreas C; Kramm C; Grüttner HP; Falkenberg E; Orth A; Bader P; Schwabe D; Klingebiel T
Bone Marrow Transplant; 2007 Mar; 39(5):269-78. PubMed ID: 17311085
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution in children following chemotherapy for acute leukemia.
Williams AP; Bate J; Brooks R; Chisholm J; Clarke SC; Dixon E; Faust SN; Galanopoulou A; Heath PT; Maishman T; Mapstone S; Patel SR; Vora A; Wilding SA; Gray JC
EJHaem; 2020 Jul; 1(1):142-151. PubMed ID: 35847713
[TBL] [Abstract][Full Text] [Related]
11. Childhood cancer: Survival, treatment modalities, late effects and improvements over time.
Erdmann F; Frederiksen LE; Bonaventure A; Mader L; Hasle H; Robison LL; Winther JF
Cancer Epidemiol; 2021 Apr; 71(Pt B):101733. PubMed ID: 32461035
[TBL] [Abstract][Full Text] [Related]
12. Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.
Lehrnbecher T; Fisher BT; Phillips B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Castagnola E; Davis BL; Dupuis LL; Egan G; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; van de Wetering M; Wolf J; Cabral S; Robinson PD; Sung L
Clin Infect Dis; 2020 Jun; 71(1):226-236. PubMed ID: 31676904
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).
Mikulska M; Cesaro S; de Lavallade H; Di Blasi R; Einarsdottir S; Gallo G; Rieger C; Engelhard D; Lehrnbecher T; Ljungman P; Cordonnier C;
Lancet Infect Dis; 2019 Jun; 19(6):e188-e199. PubMed ID: 30744964
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors.
Proudfoot R; Phillips B; Wilne S
J Pediatr Hematol Oncol; 2017 Apr; 39(3):194-202. PubMed ID: 28267082
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
